Cutaneous reaction or necrosis in response to interferon alpha: Can interferon be reintroduced after healing? Six case reports;Reactions cutanees ou necrose a l'interferon alpha: Peut-on reprendre l'interferon? A propos de six cas

Revue de Medecine Interne

Volumn 21, Issue 9, 2000, Pages 756-763

  Sparsa, A ^a   Loustaud Ratti, V ^a   Liozon, E ^a   Denes, E ^a   Soria, P ^a   Bouyssou Gauthier, M L ^a   Le Brun, V ^a   Boulinguez, S ^a   Bedane C ^a   Scribbe Outtas, M ^a   Outtas, O ^a   Labrousse, F ^a   Bonnetblanc, J M ^a   Bordessoule, D ^a   Vidal, E ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Cutaneous necrosis; Interferon

Indexed keywords

ALPHA INTERFERON; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT;

ADULT; AGED; ALOPECIA; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG USE; ERYTHEMA; FEMALE; HERPES LABIALIS; HUMAN; HUMAN TISSUE; INJECTION SITE; MALE; RASH; SKIN MANIFESTATION; SKIN NECROSIS; WOUND HEALING; BIOPSY; CASE REPORT; DRUG ERUPTION; HEPATITIS C; LEUKEMIA; MIDDLE AGED; NECROSIS; PATHOLOGY; RECURRENT DISEASE; RISK FACTOR; TIME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; BIOPSY; DRUG ERUPTIONS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LEUKEMIA; MALE; MIDDLE AGED; NECROSIS; RECURRENCE; RISK FACTORS; TIME FACTORS; WOUND HEALING;

EID: 0033825361     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(00)00221-6     Document Type: Article

References (32)

1. Interferon alfa-2b: Clinical overview and future directions
2. Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients
3. Cutaneous local necrosis following interferon injection
4. Beta interferon therapy in patients with poor prognosis Kaposi sarcoma related to the Acquired Immunodeficiency Syndrome (AIDS)
5. Severe necrotizing cutaneous lesions complicating treatment with interferon beta-1b
6. Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis
7. Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literature
8. Cutaneous ulcerations secondary to interferon alfa therapy of Kaposi's sarcoma
9. Necrose cutanee locale apres injection d'interferon alpha
10. Cutaneous necrosis associated with interferon α-2b
11. Autoimmune phenomena associated with cutaneous aseptic necrosis during interferon-alpha treatment for chronic myelogenous leukaemia
12. Necrose cutanee locale severe au cours d'un traitement par interferon alpha et ribavirine pour hepatite virale chronique C
13. Local cutaneous necrotizing lesions associated with interferon injections
14. Cutaneous necrosis caused by injection of α-interferon in a patient with chronic myelogeneous leukemia
15. Allergic contact dermatitis from beta-interferon in eyedrops
16. Psoriasis induced at the injection site of recombinant interferons
17. Pyoderma gangrenosum triggered by alpha2b-interferon in a patient with chronic granulocytic leukemia
18. Aseptische hautneckrose nach subkutaner injektion von interferon-α
19. More on interferon-induced cutaneous necrosis
20. Necrose cutanee localisee apres injection d'interferon alpha revelatrice d'une resistance a la proteine C activee. 38(e) Congres de la Societe nationale francaise de medecine interne, Bordeaux, 18-20 juin 1998
21. Cutaneous necrosis by subcutaneous injection of a interferon in a patient with chronic type B hepatitis
22. Necrose cutanee locale apres injections d'interferon beta
23. Vascularite aigue leucocytoclasique a depots d'IgA au cours d'un traitement par interferon alpha
24. Necrose cutanee apres injection d'interferon alpha (INFα) revelant 2 anomalies de l'hemostase : Resistance a la proteine C activee et deficit en methylene-tetrahydrofolate reductase. Journees dermatologiques de Paris, Paris, 2-5 decembre 1998
25. Coumarin necrosis: A review of the literature
26. High doses of natural alpha interferon in the treatment of multiple myeloma: A pilot study of the Myeloma Group of Central Sweden
27. Skin necrosis after heparin injection
28. Insulin-induced lipoatrophy; evidence for an immune pathogenesis
29. Raynaud's phenomenon and cryoglobulinemia associated with the use of recombinant human alpha interferon
30. Digital vasculitis associated with interferon therapy
31. Alpha-interferon therapy and cutaneous vascular lesions
32. Necrose cutanee apres injection d'interferon alpha revelant une resistance a la proteine C activee : Rapport d'un cas